Health-related quality of life in primary raynaud phenomenon

Journal of Clinical Rheumatology

Volumn 14, Issue 4, 2008, Pages 206-210

  De Angelis, Rossella ^a   Salaffi, Fausto ^a   Grassi, Walter ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

EUROQoL; Health related quality of life; Raynaud phenomenon; SF 36

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RAYNAUD PHENOMENON; SCORING SYSTEM; SHORT FORM 36; AGED; CASE CONTROL STUDY; MIDDLE AGED; PAIN ASSESSMENT;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; RAYNAUD DISEASE;

EID: 62849118971     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31817a2485     Document Type: Article

References (34)

1. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology. 2005;44:587-596.
2. Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud's phenomenon. Arch Intern Med. 2000;160:1101-1108.
3. Brand FN, Larson MG, Kannel WB, et al. The occurrence of Raynaud's phenomenon in a general population: the Framingham Study. Vasc Med. 1997;2:296 -301.
4. Block JA, Sequeira W. Raynaud's phenomenon. Lancet. 2001;357: 2042-2048.
5. De Angelis R, Salaffi F, Grassi W. Raynaud's phenomenon: prevalence in an Italian population sample. Clin Rheumatol. 2006;25:506 -510.
6. Merkel PA, Herlyn K, Martin RW, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 2002;46:2410 -2420.
7. Hirschl M, Katzenschlager R, Francesconi C, et al. Low level laser therapy in primary Raynaud's. Results of a placebo-controlled, double blind intervention study. J Rheumatol. 2004;31:2408 -2412.
8. Ware JE Jr, Sherbourne CD. The MOS 36-item short form healthy survey (SF-36). 1. Conceptual framework and item selection. Med Care. 1992;30:473-481.
9. Ware J, Kosinski M, Bayliss M, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;4:264 -279.
10. Brooks R, Rabin R, De Charro F. The Measurement and Valuation of Health Status Using the EQ-5D: A European Perspective. Dordrecht: Kluwer; 2003.
11. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
12. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
13. Franchignoni F, Salaffi F. Generic and specific measures for outcome assessment in orthopaedic and rheumatologic rehabilitation. In: Barat M, Franchignoni F, eds. Advances in Rehabilitation. Assessment in Physical Medicine and Rehabilitation. Vol. 16. Pavia: Maugeri Foundation Books; 2004:45-78.
14. LeRoy EC. Medsger TA Jr. Raynaud's phenomenon: a proposal of classification. Clin Exp Rheumatol. 1992;10:485-488.
15. Charlson ME, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
16. Sangha O, Stuki G, Liang M, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res. 2003;49:156 -163.
17. Salaffi F, De Angelis R, Stancati A, et al. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol. 2005;23:829-839.
18. Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol. 1998;51:1025-1036.
19. Sprangers MAG, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53:895-907.
20. Salaffi F, Carotti M, Stancati A, et al. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 2005;17:255-263.
21. Salaffi F, Carotti M, Grassi W. Health-related quality of life in patients with hip or knee osteoarthritis: comparison of generic and diseasespecific instruments. Clin Rheumatol. 2005;24:29 -37.
22. Rinaldi S, Doria A, Salaffi F, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology. 2004;43:1574 -1579.
23. Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. 2004; 43:1580 -1586.
24. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol. 1993;20:70 -76.
25. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol. 1997;24:879-889.
26. Brown KM, Middaugh SJ, Haythornthwaite JA, et al. The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: the Raynaud's treatment study. J Behav Med. 2001; 24:137-153.
27. Edwards CM, Marshall JM, Pugh M. Lack of habituation of the pattern of cardiovascular response evoked by sound in subjects with primary Raynaud's disease. Clin Sci. 1998;95:249 -260.
28. Droste H, Wollersheim H, Reyenga J, et al. Vascular and humoral sympathetic nervous system reactivity during mental arithmetic in primary Raynaud's phenomenon. Int Angiol. 1990;9:84-89.
29. Planchon B, Pistorius MA, Beurrier P, et al. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology. 1994;45:677-686.
30. Suter LG, Murabito JM, Felson DT, et al. The incidence and natural history of Raynaud's phenomenon in the community. Arthritis Rheum. 2005;52:1259 -1263.
31. Coleiro B, Marshall SE, Denton CP, et al. Treatment of Raynaud's phenomenon with the selective serotonin re-uptake inhibitor fluoxetine. Rheumatology. 2001;40:1038 -1043.
32. Middaugh SJ, Haythornthwaite JA, Thompson B, et al. The Raynaud's treatment study: biofeedback protocols and acquisition of temperature biofeedback skills. Appl Psychophysiol Biofeedback. 2001;26:251-278.
33. Freedman RR, Ianni P. Self-control of digital temperature: physiological factors and transfer effect. Psychophysiology. 1983;20:682-689.
34. Hedges DW, Brown BL, Shwalb DA, et al. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a metaanalysis of double-blind, placebo-controlled trials. J Psychopharmacol. 2007;21:102-111.